AzTrials
AzTrials

PtsdPE-VVSNCT06718387

Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence

A study testing PsychoEducation Program in people with Ptsd and Sexual Violence, run by Centre Hospitalier Charles Perrens, Bordeaux at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Evaluation of the impact of a psycho-education program for victims of sexual violence, to determine the most efficient model to patients. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Ptsd, Sexual Violence, Therapeutic Alliance
What is being tested?
PsychoEducation Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
1 Apr 2023to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • At the suggestion of CRP therapists,
  • Patient treated at the CRP having been exposed to sexual violence

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Centre Hospitalier Charles PERRENS

    Bordeaux, 33076

    Chantal BERGEY, MD, 05 56 56 35 78, cbergey@ch-perrens.fr

    Celine PELEAU, 05 56 56 35 78, ctroadec@ch-perrens.fr

    Recruiting

Other trials in France

About this study

Evaluation of the impact of a psycho-education program for victims of sexual violence, to determine the most efficient model to patients.

Read the detailed description

In 2022, CRP Sud NA set up a psycho-education group for victims of sexual violence (PE-VVS). Two groups were held, involving 10 patients:

  • Average age = 35 (29-50)
  • Average PCL5 before PE-VSS = 53 (31 - 63)
  • Type of SV experienced
  • In childhood or adolescence outside family environment
  • Incest
  • Rape in adulthood outside intimate relationship
  • Rape by intimate partner A special feature of this therapeutic group is the involvment of the CRP's patient-partner. He took part in both design and facilitation of the sessions, along with the two CRP co-therapists (IDE / psychologist).
Being tested
PsychoEducation Program
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PsychoEducation ProgramOther

    6 sessions of PsychoEducational Program

Study groups in NCT06718387
Study groupRoleWhat they receive
Without group interventionNo interventionPatient refusing group care and/or assessment ended after the inclusion end dates
With group interventionExperimentalPatient in agreement with group management and available for participation
Receives: Other: PsychoEducation Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of impact on quality of life (QoL) concerning participation in this psychoeducation program

    QoL measurement by Stages of Recovery Instrument "STORI"

    Measured: 6 months after the end of program

  2. Evaluation of impact on self-esteem of participation in this psychoeducation program

    Self-esteem measurement by Rosenberg self-esteem scale

    Measured: 6 months after the end of program

  3. Evaluation of Impact on mental well-being of participation in this psychoeducation program

    Well-being evalutation by Warwick-Edinburgh scale (WEMWBS)

    Measured: 6 months after the end of program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2024
  2. Study start1 Apr 2023
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06718387
Sponsor's protocol ID
CR-BDX-AP 2023-08
Acronym
PE-VVS
Status last verified
Mar 2026
First submitted
29 Nov 2024
Last updated
16 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Millon EM, Shors TJ. Taking neurogenesis out of the lab and into the world with MAP Train My Brain. Behav Brain Res. 2019 Dec 30;376:112154. doi: 10.1016/j.bbr.2019.112154. Epub 2019 Aug 14.

    PubMed 31421141
  • Shors TJ, Millon EM. Sexual trauma and the female brain. Front Neuroendocrinol. 2016 Apr;41:87-98. doi: 10.1016/j.yfrne.2016.04.001. Epub 2016 Apr 13.

    PubMed 27085856
  • Shors TJ, Olson RL, Bates ME, Selby EA, Alderman BL. Mental and Physical (MAP) Training: a neurogenesis-inspired intervention that enhances health in humans. Neurobiol Learn Mem. 2014 Nov;115:3-9. doi: 10.1016/j.nlm.2014.08.012. Epub 2014 Sep 9.

    PubMed 25219804

Questions about this trial

What is this clinical trial studying?

A study testing PsychoEducation Program in people with Ptsd and Sexual Violence, run by Centre Hospitalier Charles Perrens, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chantal BERGEY, MD (05 56 56 35 78, cbergey@ch-perrens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of impact on quality of life (QoL) concerning participation in this psychoeducation program (time frame: 6 months after the end of program). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06718387, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in